We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Spero Therapeutics Inc
8 own
13 watching
Current Price
$1.77
$0.02
(1.14%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
92.85M
52-Week High
3.18
52-Week Low
0.6801
Average Volume
0.12M
Dividend Yield
--
P/E Ratio
--
Market Capitalization92.85M52-Week High3.1852-Week Low0.6801Average Volume0.12MDividend Yield--P/E Ratio--What does the Spero Therapeutics Inc do?
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company s product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; license agreement with Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; collaboration agreement with Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis; and license agreement with Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Spero Therapeutics Inc make?
News & Events about Spero Therapeutics Inc.
Globe Newswire
1month ago
CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) ...
Globe Newswire
2 months ago
CAMBRIDGE, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas, involving rare diseases and multi-drug resistant (MDR) ...
Globe Newswire
2 months ago
CAMBRIDGE, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas, involving rare diseases and multi-drug resistant (MDR) ...
Globe Newswire
2 months ago
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR...
Globe Newswire
6 months ago
CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR...
Frequently Asked Questions
Frequently Asked Questions
What is Spero Therapeutics Inc share price today?
Can Indians buy Spero Therapeutics Inc shares?
How can I buy Spero Therapeutics Inc shares from India?
Can Fractional shares of Spero Therapeutics Inc be purchased?
What are the documents required to start investing in Spero Therapeutics Inc stocks?
What is today’s traded volume of Spero Therapeutics Inc?
What is today’s market capitalisation of Spero Therapeutics Inc?
What is the 52-Week High and Low Range of Spero Therapeutics Inc?
What percentage is Spero Therapeutics Inc down from its 52-Week High?
What percentage is Spero Therapeutics Inc up from its 52-Week Low?
Current Price
$1.77
$0.02
(1.14%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.